CINECA IRIS Institutional Research Information System

MANCINA, ROSELLINA MARGHERITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 329
EU - Europa 67
NA - Nord America 59
SA - Sud America 6
AF - Africa 3
Totale 464
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 174
SG - Singapore 140
US - Stati Uniti d'America 54
GB - Regno Unito 13
IT - Italia 7
LT - Lituania 7
SE - Svezia 6
DE - Germania 5
NL - Olanda 5
BE - Belgio 4
CA - Canada 4
CH - Svizzera 3
EE - Estonia 3
PE - Perù 3
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
ID - Indonesia 2
IE - Irlanda 2
KG - Kirghizistan 2
PL - Polonia 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
CN - Cina 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
IN - India 1
JM - Giamaica 1
JP - Giappone 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
TR - Turchia 1
Totale 464
Salva come PNG Salva come JPEG
Città #
Hong Kong 174
Singapore 43
London 8
Los Angeles 7
Frankfurt am Main 5
Gothenburg 5
Brussels 4
Ashburn 3
Lima 3
Ottawa 3
Tallinn 3
Zurich 3
Amsterdam 2
Athens 2
Bishkek 2
Bratislava 2
Cairo 2
Dublin 2
Florence 2
Riyadh 2
Almaty 1
Antalya 1
Bogotá 1
Buenos Aires 1
Colombo 1
Dhaka 1
Dubai 1
Guayaquil 1
Lisbon 1
Luxembourg 1
Mumbai 1
Newark 1
Nicosia 1
Rabat 1
Rome 1
Santa Clara 1
Stockholm 1
Tirana 1
Tokyo 1
Toronto 1
Warsaw 1
Totale 298
Salva come PNG Salva come JPEG
Nome #
ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity 14
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity 14
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 13
PSD3 downregulation confers protection against fatty liver disease 13
Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults 13
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia 12
Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant 12
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 12
The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children 11
Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma 11
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 11
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 11
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 10
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans 10
Cross talk between liver and adipose tissue: A new role for PNPLA3? 10
Gastrointestinal Symptoms of and Psychosocial Changes in Inflammatory Bowel Disease: A Nursing-Led Cross-Sectional Study of Patients in Clinical Remission 10
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 10
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 10
Genetic diagnosis of familial hypercholesterolaemia by targeted next‐generation sequencing 10
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 9
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 9
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 9
Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function 9
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells 9
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 9
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 9
Validation of Interleukin-32 as a new circulating fatty liver biomarker 9
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover 9
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 9
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans 9
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans 9
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids 9
Genetic variants in the MTHFR are not associated with fatty liver disease 9
TM6SF2 and PNPLA3: a potential dynamic duo? 9
PNPLA3 I148M polymorphism and progressive liver disease 8
The IRS1 rs2943641 Variant and Risk of Future Cancer Among Morbidly Obese Individuals 8
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome 8
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning 8
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease 8
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes 8
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 8
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History 8
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 8
Natural Extracts as Modifiers of Intracellular Lipid Handling 8
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver 8
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels 7
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice 7
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 7
Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan 7
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage 7
Statin use and non-alcoholic steatohepatitis in at risk individuals 7
PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity 7
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 7
MBOAT7 is anchored to endomembranes by six transmembrane domains 7
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia 7
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 6
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 6
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells 6
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 6
High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease 6
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 5
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 5
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals 5
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 5
Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children 5
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro 5
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 5
Totale 575
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.465
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202467 0 0 0 0 0 0 0 0 30 36 0 1
2024/2025508 19 55 2 9 98 147 76 25 66 11 0 0
Totale 575